MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IRWD had $5,015K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$5,015K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net income (loss)
    • Deferred income taxes
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Accounts receivable, net
    • Accounts payable and accrued exp...
    • Accrued research and development...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Loss on disposal of property and equipment
-3 -7 -85
Net income (loss)
40,773 -2,276 40,080 -13,787
Depreciation and amortization
443 460 475 946
Share-based compensation expense
3,653 3,823 3,612 9,815
Non-cash interest expense
419 418 418 832
Non-cash lease expense
444 435 426 827
Deferred income taxes
19,196 -1,746 27,772 14,775
Accounts receivable, net
59,097 -73,623 34,193 4,282
Prepaid expenses and other current assets
-5,997 -1,086 248 471
Other assets
-121 -100 -63 -284
Accounts payable and accrued expenses
-4,886 -318 10,693 -4,174
Accrued research and development costs
-1,102 -274 -1,168 -2,664
Operating lease liabilities
-621 -612 -603 -1,156
Other liabilities
-219 -141 249 3,856
Net cash provided by operating activities
5,121 74,575 47,583 4,886
Purchases of property and equipment
--1 2 33
Net cash used in investing activities
-1 -2 -33
Proceeds from exercise of stock options and employee stock purchase plan
-122 0 94
Net cash provided by (used in) financing activities
-122 0 94
Effect of exchange rate changes on cash and cash equivalents
-106 351 -26 -654
Net increase in cash and cash equivalents
5,015 75,049 47,555 4,293
Cash and cash equivalents, beginning of period
215,456 140,407 88,559 -
Cash and cash equivalents, end of period
220,471 215,456 140,407 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income (loss)$40,773K Deferred income taxes$19,196K Prepaid expenses andother current assets-$5,997K Share-based compensationexpense$3,653K Non-cash lease expense$444K Depreciation andamortization$443K Non-cash interestexpense$419K Other assets-$121K Net cash provided byoperating activities$5,121K Canceled cashflow$65,925K Net increase in cashand cash...$5,015K Canceled cashflow$106K Accounts receivable, net$59,097K Accounts payable andaccrued expenses-$4,886K Accrued research anddevelopment costs-$1,102K Operating leaseliabilities-$621K Other liabilities-$219K Effect of exchange ratechanges on cash and cash...-$106K

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)